Objectives

After participating in this educational activity, attendees should be able to:

1|Recognize the impact of mandated reporting for newborn substance exposure.
2|Define the most up-to-date mandating reporting laws
3|Describe best practices in perinatal drug testing, and how results mandated reporting
4|Present the NEW Baystate policy/guideline for 51A reporting for substance-exposed newborns

Presenter(s): 
Megan R. Miller, MD
Obstetrician/Gynecologist
Assistant Professor, OB/GYN
UMass Chan - Baystate
 

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Megan Miller, MD, FACOG, FASAM  Speaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
02/04/2025 - 8:00am to 9:00am EST
Location: 
Chestnut 1 A/B
759 Chestnut Street
Springfield, MA 01199
United States
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)

Please login or register to take this course.